Abstract
This review focuses on the scenario of Indian manufacturers, biotherapeutics approvals in India and important aspects which need to be precisely analyzed and resolved from the Indian perspective to facilitate implementation of global guidelines for the manufacture of these products, to best serve the public health needs of the developing countries. © 2011.
Author supplied keywords
Cite
CITATION STYLE
APA
Babu, P. V. C. (2011). An Indian manufacturer’s perspective for harmonization of guidelines for similar biotherapeutic products. Biologicals, 39(5), 300–303. https://doi.org/10.1016/j.biologicals.2011.06.022
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free